newsfilter
← Latest News
GlobeNewswire·

YD Bio Limited Showcases Its Innovative Diagnostic and Precision Medicine Portfolios at the 9th Healthcare EXPO TAIWAN

  • YD Bio Limited (NASDAQ: YDES) successfully participated in the 9th Healthcare Expo Taiwan held from December 4-7, 2025, at TaipeiNEX 1.
  • The company exhibited at Booth No. 4F, M1004, showcasing advances in DNA methylation-based cancer detection, ophthalmologic precision diagnostics, stem cell therapy, exosome platforms.
  • The 4-day event attracted over 1,500 visitors 541 on-site surveys, serving as a gateway to connect with hospitals, tech giants, biotech innovators.
  • YD Bio engaged with international distributors from China, Hong Kong, Indonesia, Dubai who expressed strong interest in collaborating to expand OkaiDx™ cancer detection ophthalmologic product portfolios.
  • Discussions included utilizing EG BioMed US Inc.'s CLIA-certified CAP-accredited U.S. laboratory as a global central lab for precision cancer testing services.
  • Chairman CEO Dr. Ethan Shen highlighted the expo's role in showcasing advancements advancing the company's pragmatic path from development to revenue.
  • YD Bio remains committed to expanding global access to precision cancer detection preventive healthcare solutions through these new international partnerships.